Improving molecular testing and personalized medicine in non-small-cell lung cancer in Ontario

https://phgkb.cdc.gov/GAPPKB/phgHome.do

From Guideline Database

This database contains updated guidelines, policies and recommendations on genomic research and practice, as provided by professional organizations, federal advisory groups, expert panels and policy groups.

---

• Improving molecular testing and personalized medicine in non-small-cell lung cancer in Ontario.  
  Published 2017 (Expert panel)
• ALK-Testing in non-small cell lung cancer (NSCLC): Immunohistochemistry (IHC) and/or fluorescence in-situ Hybridisation (FISH)?: Statement of the Germany Society for Pathology (DGP) and the Working Group Thoracic Oncology (AIO) of the German Cancer Society e.V. (Stellungnahme der Deutschen Gesellschaft fur Pathologie und der AG Thorakale Onkologie der Arbeitsgemeinschaft Onkologie/Deutsche Krebsgesellschaft e.V.).  
  Published 2017 (Germany Society for Pathology (DGP)) (Working Group Thoracic Oncology (AIO) of the German Cancer Society e.V. (Stellungnahme der Deutschen Gesellschaft fur Pathologie und der AG Thorakale Onkologie der Arbeitsgemeinschaft Onkologie/Deutsche Krebsgesellschaft e.V.))
• National Working Group Meeting on ALK diagnostics in lung cancer.  
  Published 2014 (Pfizer-sponsored National Working Group Meeting on ALK Diagnostics in Lung Cancer)
• Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update.  
  Published 2015 (American Society of Clinical Oncology (ASCO))
• Final Recommendation Statement: Lung Cancer: Screening, December 2013  
  Published 2013 (US Preventive Services Task Force)

more